EP-1716: Prospective electronic toxicity registration to audit NTCP models and dose constraints  by Janssen, T. et al.
S802                                                                                                                                                  ESTRO 35 2016 
_____________________________________________________________________________________________________ 
Purpose or Objective: To correlate a Neural Network (NN) 
predictive model to clinical outcome of toxicities of patients 
undergone Radiation Therapy (RT). A re-plan strategy was 
evaluated highlighting challenges and advantage of an 
Adaptive RT (ART) workload. Clinical outcomes were assessed 
to validate an algorithm based on IGRT and deformable image 
registration. 
 
Material and Methods: A cohort of 30 Head and Neck (H&N) 
patients, previously treated by Tomotherapy and CHT 
concomitant, was investigated: 19 male and 11 female 
[48÷89 years] with mean KPS index 95.5. To take into account 
inter-fractions organ warping, 900 pre-treatment MVCT study 
were deformed by RayStation and a dose accumulation 
analysis was performed. Exported data were used to train the 
predictive NN tool: a MATLAB toolbox developed to identify 
patients eligible for re-planning. Using a retrospective 
approach, the toxicity data were investigated with a mean 
follow-up period of 12 months. Weight (before and after RT), 
smoker number and toxicity information were considered. 
Correlation was assessed using SPSS statistic. 
 
Results: Analysis on the follow-up DB showed that 74% of 
patients were affected by early toxicity: 40% (G1), 25% (G2) 
and 9% (G3); 41% by late toxicity: 30% (G1), 10% (G2) and 1% 
(G3). Correlating the medium-high grade of early toxicity 
with the dose of the event occurred, a 2nd order polynomial 
correlation was detected with a R2 value of 0.93 for G2 and 
0.92 for G3. 
 
 
The correlation of smoking and low toxicity (i.e. dysphagia, 
dysgeusia, mucositis, salivation) showed a mean G1 
increased. An increased frequency of early (21%) and late 
(19%) toxicity was detected for smoker patients, with an 
ANOVA multivariate significance of 3.8% and 0.6% 
respectively. Simultaneously, a NN weekly method was 
carried out to follow and predict anatomical variations during 
RT. A benefit due to a review of the initial plan was 
estimated for 89.6% of patients. The need of re-planning was 
correlated with weight loss. 37% of patients do not need a re-
plan and 25% of them had a weight loss <5%. 63% of patients 
would benefit for a re-plan: during the 2nd week for 25% of 
cases with a weight decrease <10%; during the 4th week for 
remaining 38% of cases (25% of them had a weight loss >10%). 
 
 
 
Conclusion: The machine learning approaches could support 
decision making in ART workload. Descriptive and inferential 
analysis showed a correlation between NN outcome and 
follow-up data, making robust the predictive approach based 
on organ warping and dose deformation. An increased 
number of cases have to be analyzed to train self-learning 
algorithm and to ensure personalization of patients’ 
treatment. Patients with an abnormal weight loss, smoker 
and with a high dose delivered should be investigated to 
avoid early and late toxicities. 
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Purpose or Objective: In 2012 we started with the 
prospective, electronic registration by the treating physician 
of all grade ≥2 toxicities (CTCAE v4.0) for all patients 
irradiated at our department. Simultaneously we set up an 
infrastructure to couple this data to dose and treatment 
parameters. The aim of this work is to show the feasibility of 
such an infrastructure to audit toxicity prediction models and 
dose constraints in daily clinical practice. 
 
Material and Methods: As a showcase we consider the 
relation between the esophagus V50Gy and grade ≥2 
esophagitis in locally advanced NSCLC patients receiving 
concurrent chemoradiotherapy (CCRT; 24 x 2.75 Gy and daily 
6mg/m2 cisplatin). Clinically we use the criterion V50Gy < 
50% as a dose constraint based on a previously developed 
NTCP model (Kwint et al. IJROBP 2012). The applicability of 
this model to current daily clinical practice, however, is not 
evident since CCRT patients currently receive intravenous 
pre-hydration (1L, NaCl 0.9%) which was shown to decrease 
esophagitis (Uyterlinde et al. R&O 2014).  
For all CCRT patients (excluding re-irradiations of the 
thoracic region) treated since January 2013, the planned 
V50Gy and the registered esophagitis ≥grade 2 were 
automatically retrieved. Patients with toxicity registration in 
at least 50% of the consultations were included. We 
calculated the cumulative incidence of grade ≥2 esophagitis 
per V50Gy and compared this with the expected incidence 
based upon the model by Kwint et al. using a χ2 test. ROC 
analysis was performed to assess the predictive value of 
V50Gy. 
 
Results: For 286 patients, a total of 1842 consultations were 
performed. The incidence of toxicity was electronically 
registered in 76% of these visits. For 229 patients (80%) the 
incidence of toxicity was registered in >50% of consultations. 
Median follow up was 3.5 months. A graphic comparison of 
the observed and predicted incidence of grade ≥2 esophagitis 
is shown in figure 1a. The observed incidence of grade ≥2 
esophagitis was 51.1% while the model predicts 52.1% 
(p=0.89). ROC analysis (figure 1b) resulted in an area under 
the curve of 0.69. To rule out a selection bias towards 
increased toxicity, the analysis was repeated for all 286 
patients, assuming that no toxicity occurred for missing 
registrations, with very similar results. 
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Conclusion: The observed and predicted dose-effect of grade 
≥2 esophagitis were almost identical. This implies that our 
esophagus dose parameter accurately predicts toxicity for 
our current patient population and treatment protocol. This 
result is surprising, since esophagitis incidence was expected 
to decrease because of the introduced pre-hydration. While 
the origin of this discrepancy requires further investigation, 
it does show that the electronic toxicity scoring system and 
connection to the dose parameters appears to be a useful 
and valuable tool to audit the applicability of dose 
constraints in daily clinical practice. 
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Purpose or Objective: The radiosensitivity of cells has an 
oxygen dependence that leads to an undesired resistance of 
hypoxic tumour cells. This is well known[1] and the linear 
quadratic response model has been extended to account for 
it.[2] In order to properly model tumour responses, the 
information about the distribution of oxygen at a microscopic 
scale must be available.[3] Modelling works usually derive 
this distribution by solving the reaction-diffusion equation in 
a voxelized tumour geometry that includes a vascularization 
distribution model.[4] However, the oxygen available to the 
cells increases during radiotherapy due to, among other 
factors, cell killing. This reoxygenation process can turn 
hypoxic cells into oxic, changing the cells radiosensitivity 
during the treatment. In this work we implement two models 
of cell death kinetics, CDKM, to analyse how they affect 
reoxygenation and hence the response of tumours to 
radiotherapy. 
 
Material and Methods: Two CDKMs are compared:  
a) Delayed cell killing model, DCDKM: The number of dead 
cells after irradiation varies with time according to an 
exponential expression. Cells can die shortly or long after 
irradiation, mimicking early and late apoptosis.  
b) Instantaneous cell killing model, ICDKM: Cell death occurs 
immediately after irradiation (early apoptosis scenario).  
Using these models, oxygen distributions are recomputed 
before the delivery of each fraction, considering the 
decrease in oxygen consumption due to cell death caused 
during the previous fractions. The oxygen consumption can 
be computed globally, by voxel averaging surviving fractions, 
or locally, at a subvoxel scale. The differences in 
reoxygenation and tumour response arising under different 
CDKM and oxygen consumption scenarios depend on the 
vascular fraction, VF, and the fractionation scheme. This was 
illustrated for a conventional schedule and a 
hypofractionated treatment. 
 
Results: In the conventional treatment, the doses needed to 
achieve 50% tumour control (D50) are ~ 10 and 2 Gy larger 
under the ICDKM (for VFs of 1% and 3%, respectively). 
Differences are larger in the hypofractionated scheme, for 
which the TCP remains equal to zero under the DCDKM for a 
VF equal to 1%. For a VF equal to 3%, D50 values are ~ 20 Gy 
larger under the DCDKM. Similar results were found under the 
global and local oxygen consumption calculations. 
 
Conclusion: This work shows that the kinetics of cell death 
can have a great impact in the simulation of reoxygenation 
and tumour response. Radiation response models should 
account for cell death kinetics to properly evaluate tumour 
response, especially in hypofractionated schemes. 
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Purpose or Objective: The project aims at predicting tumor 
radiation starting from pre-treatment information related to 
cancer volume and oxygenation. 
 
Material and Methods: Eighteen Copenhagen rats, implanted 
with prostate tumor, underwent two irradiations (2x15Gy). 
Nine rats were treated in standard conditions (Air), while the 
remaining group (Oxy) inhaled oxygen. Before the first 
irradiation, an interleaved blood (BOLD) and tissue (TOLD) 
oxygen level dependent (IBT) MRI sequence was performed. 
Four indices were computed, namely, BOLD and TOLD signal 
intensity variation (dSI), and the change in longitudinal (dR1) 
and transverse (dR2*) relaxation rate. The tumor volume 
evolution was monitored by means of weekly caliper 
measurements. A two-equation system describing the 
uncontrolled growth and the response to treatment of the 
active cells population, along with the dead cell clearance 
dynamics, was implemented in Matlab® (MathWorks, Natick, 
Massachusetts, USA). Three parameters, namely the volume 
doubling time, the radiation sensitivity (α) and the dead cell 
clearance time, were learned on a subject-specific basis 
using a genetic algorithm. Finally, a feed forward neural 
network (FF-ANN) was trained (Fig. 1) to predict α starting 
from the MRI indices and initial volume, for each group 
(Air/Oxy). 
 
